HCPCS Level II Q5137: Ustekinumab-auub (Wezlana) 1 mg Subcutaneous Injection
HCPCS Level II code Q5137 describes a subcutaneous injection of ustekinumab-auub (Wezlana) biosimilar provided as a 1 mg unit; this code is used to report administration of the biologic agent for outpatient ambulatory or clinic-based subcutaneous injections where the clinician or facility documents the specific drug and dosage administered.
For related coverage guidance, see recent payer policy updates: B-Hemolytic Streptococcus Testing, Human Immunodeficiency Virus (HIV) — Coverage Criteria for Testing and Resistance Assays, Hepatitis Testing (A, B, C, D) Coverage Criteria.
Customize your policy alerts
Sign up for hcpcs Q5137 policy alerts
Get alerted when payer policies referencing Q5137 are released or updated.
Monitor payer policy activity